Chimeric Diphtheria Toxin-CCL8 Cytotoxic Peptide for Breast Cancer Management

The specificity of a chimeric cytotoxic peptide was confirmed in vitro by testing the cytotoxic activity of breast cancer cells overexpressing CCR5, a major CCL8 receptor, and by a neutralizing anti-CCL8 antibody they developed.